Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | thymidine phosphorylase | 0.7917 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0284 | 0.0313 | 0.6877 |
Entamoeba histolytica | protein kinase, putative | 0.0284 | 0.0313 | 0.5 |
Onchocerca volvulus | Dual specificity protein kinase TTK homolog | 0.0362 | 0.0412 | 1 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0284 | 0.0313 | 1 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.2235 | 0.2789 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0362 | 0.0412 | 0.2108 |
Brugia malayi | serine/threonine kinase 12 | 0.0284 | 0.0313 | 0.1599 |
Loa Loa (eye worm) | TTK protein kinase | 0.0362 | 0.0412 | 0.2108 |
Leishmania major | protein kinase, putative | 0.0284 | 0.0313 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0284 | 0.0313 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0284 | 0.0313 | 0.6877 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0284 | 0.0313 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0362 | 0.0412 | 1 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0284 | 0.0313 | 1 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.7917 | 1 | 1 |
Giardia lamblia | Kinase, TTK | 0.0362 | 0.0412 | 1 |
Loa Loa (eye worm) | AUR protein kinase | 0.0284 | 0.0313 | 0.1599 |
Echinococcus granulosus | dual specificity serine:threonine tyrosine | 0.0362 | 0.0412 | 0.0103 |
Entamoeba histolytica | protein kinase , putative | 0.0284 | 0.0313 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0284 | 0.0313 | 0.6877 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0284 | 0.0313 | 0.1599 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0362 | 0.0412 | 1 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0284 | 0.0313 | 0.1599 |
Schistosoma mansoni | dual specificity serine/threonine tyrosine kinase | 0.0362 | 0.0412 | 1 |
Mycobacterium ulcerans | anthranilate phosphoribosyltransferase | 0.2235 | 0.2789 | 0.2789 |
Trichomonas vaginalis | AGC family protein kinase | 0.0284 | 0.0313 | 0.6877 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0284 | 0.0313 | 0.5 |
Toxoplasma gondii | aurora kinase | 0.0284 | 0.0313 | 1 |
Brugia malayi | hypothetical protein | 0.1578 | 0.1956 | 1 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0284 | 0.0313 | 0.5 |
Echinococcus multilocularis | dual specificity serine:threonine tyrosine | 0.0362 | 0.0412 | 0.0103 |
Trypanosoma brucei | aurora B kinase | 0.0284 | 0.0313 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0284 | 0.0313 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1578 | 0.1956 | 1 |
Brugia malayi | hypothetical protein | 0.0111 | 0.0094 | 0.0479 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0284 | 0.0313 | 0.5 |
Loa Loa (eye worm) | AUR protein kinase | 0.0284 | 0.0313 | 0.1599 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0094 | 0.0479 |
Loa Loa (eye worm) | AUR protein kinase | 0.0284 | 0.0313 | 0.1599 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.7917 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 6.25 ug ml-1 | Antibacterial activity against Escherichia coli NIHJ JC-2 | ChEMBL. | 6422043 |
MIC (functional) | = 6.25 ug ml-1 | Antibacterial activity against Escherichia coli NIHJ JC-2 | ChEMBL. | 6422043 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity against Staphylococcus aureus 209PJC-1 | ChEMBL. | 6422043 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity against Pseudomonas aeruginosa Tsuchijima | ChEMBL. | 6422043 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.